Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/28/2025

Managing Clozapine-Induced Tachycardia with Metoprolol

Introduction to Metoprolol Dosing

  • The American College of Cardiology and American Heart Association guidelines support metoprolol titration for tachycardia management, with metoprolol succinate doses reaching up to 95 mg daily demonstrating efficacy in reducing heart rate in patients with inappropriate sinus tachycardia 1, 2
  • The maximum daily maintenance dose for metoprolol tartrate is 200 mg twice daily (400 mg total), and for metoprolol succinate extended-release, the maximum is 400 mg once daily 3

Initial Dosing and Titration

  • Initial dosing for metoprolol tartrate is 25-50 mg twice daily or 50-200 mg once daily for metoprolol succinate, with a recommended titration schedule of increasing gradually every 1-2 weeks if heart rate control is not achieved 4
  • The target heart rate is 50-60 beats per minute unless limiting side effects occur 4

Safety Considerations

  • Before escalating the dose, check for absolute contraindications such as AV block greater than first degree, SA node dysfunction, decompensated heart failure, severe hypotension, active asthma, or severe reactive airway disease 3, 4
  • Monitor blood pressure and heart rate at 1-2 week intervals during titration 4

Practical Titration Strategy

  • Increase metoprolol to 50mg daily and continue titration in 25-50mg increments every 1-2 weeks until heart rate is controlled or maximum tolerated dose is reached 4
  • Target a resting heart rate of 50-60 bpm unless limiting side effects develop 4

Alternative Considerations

  • If metoprolol fails to control tachycardia, consider combination therapy with ivabradine (7.5 mg twice daily) which has shown superior heart rate reduction compared to metoprolol alone in refractory cases 1, 2

Common Pitfalls to Avoid

  • Underdosing: starting at 25mg and stopping there is inadequate, as most patients require higher doses for rate control 1, 2
  • Premature discontinuation due to hypotension, which often improves with time and does not necessitate stopping therapy 5
  • Ignoring bronchospasm: monitor for wheezing during titration, though metoprolol's beta-1 selectivity makes this less likely than with non-selective agents 3, 5